TESARO Announces Data Presentations at the 2019 SGO Annual Meeting on Women’s Cancer


You May Also Like

Nanosphere Announces Record Preliminary Q4 and Full Year 2015 Results

Preliminary Fourth Quarter Revenue of $6.8 MillionPreliminary Full Year Revenue of $21.0 Million Exceeding ...

ThromboGenics Business Update – Q3 2017

Press release                                                          20 October, 2017Regulated Information Diabetic Eye Disease programs progressing €53.7 million cash ...